chr1-171635954-T-G

Variant summary

Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2_SupportingPP3

This summary comes from the ClinGen Evidence Repository: The c.1486A>C variant in MYOC is a missense variant predicted to cause substitution of Threonine by Proline at amino acid 496 (p.Thr496Pro). This variant was not found in any population of gnomAD (v2.1.1), meeting the ≤ 0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles. The REVEL score = 0.704, which met the ≥ 0.7 threshold for PP3, predicting a damaging effect on MYOC function. There was no functional evidence predicting a damaging or benign impact of this variant on MYOC function. Only 1 proband with primary open angle glaucoma had been reported (PMID:33793440), not meeting the ≥ 2 probands threshold required to meet PS4_Supporting. In summary, this variant met the criteria to receive a score of 2 and to be classified as a variant of uncertain significance (uncertain significance classification range -1 to 5) for primary open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): PP3, PM2_Supporting LINK:https://erepo.genome.network/evrepo/ui/classification/CA343722900/MONDO:0007665/019

Frequency

Genomes: not found (cov: 32)

Consequence

MYOC
NM_000261.2 missense

Scores

5
5
9

Clinical Significance

Uncertain significance reviewed by expert panel U:1

Conservation

PhyloP100: 0.711
Variant links:
Genes affected
MYOC (HGNC:7610): (myocilin) MYOC encodes the protein myocilin, which is believed to have a role in cytoskeletal function. MYOC is expressed in many occular tissues, including the trabecular meshwork, and was revealed to be the trabecular meshwork glucocorticoid-inducible response protein (TIGR). The trabecular meshwork is a specialized eye tissue essential in regulating intraocular pressure, and mutations in MYOC have been identified as the cause of hereditary juvenile-onset open-angle glaucoma. [provided by RefSeq, Jul 2008]
MYOCOS (HGNC:53429): (myocilin opposite strand)

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 2 ACMG points.

PM2
PP3

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
MYOCNM_000261.2 linkuse as main transcriptc.1486A>C p.Thr496Pro missense_variant 3/3 ENST00000037502.11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
MYOCENST00000037502.11 linkuse as main transcriptc.1486A>C p.Thr496Pro missense_variant 3/31 NM_000261.2 P1
MYOCOSENST00000637303.1 linkuse as main transcriptc.235-2676T>G intron_variant 5 A2
MYOCENST00000638471.1 linkuse as main transcriptc.*824A>C 3_prime_UTR_variant, NMD_transcript_variant 4/45

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
32

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

Open-angle glaucoma Uncertain:1
Uncertain significance, reviewed by expert panelcurationClinGen Glaucoma Variant Curation Expert PanelFeb 15, 2023The c.1486A>C variant in MYOC is a missense variant predicted to cause substitution of Threonine by Proline at amino acid 496 (p.Thr496Pro). This variant was not found in any population of gnomAD (v2.1.1), meeting the <=0.0001 threshold set for PM2_Supporting in a population of at least 10,000 alleles. The REVEL score = 0.704, which met the >=0.7 threshold for PP3, predicting a damaging effect on MYOC function. There was no functional evidence predicting a damaging or benign impact of this variant on MYOC function. Only 1 proband with primary open angle glaucoma had been reported (PMID: 33793440), not meeting the >=2 probands threshold required to meet PS4_Supporting. In summary, this variant met the criteria to receive a score of 2 and to be classified as a variant of uncertain significance (uncertain significance classification range -1 to 5) for primary open angle glaucoma based on the ACMG/AMP criteria met, as specified by the ClinGen Glaucoma VCEP (v1, 12 Oct 2021): PP3, PM2_Supporting -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Pathogenic
0.23
D
BayesDel_noAF
Uncertain
0.090
CADD
Benign
23
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.87
D
Eigen
Uncertain
0.22
Eigen_PC
Benign
0.13
FATHMM_MKL
Benign
0.26
N
LIST_S2
Benign
0.72
T
M_CAP
Benign
0.055
D
MetaRNN
Uncertain
0.66
D
MetaSVM
Uncertain
-0.082
T
MutationAssessor
Pathogenic
3.3
M
MutationTaster
Benign
0.85
D
PrimateAI
Benign
0.31
T
PROVEAN
Benign
-2.3
N
REVEL
Pathogenic
0.70
Sift
Benign
0.067
T
Sift4G
Benign
0.061
T
Polyphen
0.98
D
Vest4
0.45
MutPred
0.60
Loss of stability (P = 0.136);
MVP
0.95
MPC
0.75
ClinPred
0.94
D
GERP RS
0.90
Varity_R
0.94
gMVP
0.96

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr1-171605094; API